Giving chemotherapy before a stem cell transplant stops the growth of cancer cells by stopping them from dividing or killing them.
A primary outcome measure for phase 1 of the trial is determining the safety of oral LOXO-292.
After phase 1, the study will expand in a second phase to test the efficacy of these drugs at the determine dosage.
Combination chemotherapy and temsirolimus may stop the growth of tumor cells by blocking some of the enzymes needed for cell growth.
The purpose of this study is to assess the safety, tolerability, and antitumor activity, as well as recommended dose of brentuximab vedotin in combination with a multiagent chemotherapy regimen.
Preview key themes and trends that will be presented during the Society of Gynecologic Oncology (SGO)’s 50th Annual Meeting on Women’s Cancer.
Researchers are seeking to assess a physical activity program program in patients with gastrointestinal cancer.
Researchers are seeking to determine the feasibility of receiving either postoperative chemoradiation or chemotherapy, based on nodal status at surgery.
Researchers are seeking to assess the initial safety and efficacy of LUM015 imaging of colorectal, pancreatic, and esophageal cancers using the LUM 2.6 imaging device.